Immucell Corp (ICCC) Swings to Q2 Profit

Immucell Corp (NASDAQ: ICCC) reported Q2 EPS of $0.01, versus ($0.09) reported last year. Revenue for the quarter came in at $1.18 million, versus $1.25 million reported last year.

The Estimize consensus was $0.00 and $0 , respectively.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Lindsay, Palantir rise premarket; Ouster, Bending Spoons fall
• Compass Point Reiterates Buy Rating on Applied Digital (APLD)